1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SHUTTLE PHARMACEUTICALS HOLDINGS INC
Shuttle Pharmaceuticals Holdings Inc XNAS: SHPH
Download real time
3.59 0.11 (3.16%)
93.62% Fall from 52W High
92,826
XNAS Volume
High volume today

XNAS 12 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Shuttle Pharmaceuticals Holdings Inc

The latest disclosure was made by Oleh Nabyt in Shuttle Pharmaceuticals Holdings Inc where a trade of 29,240 Restricted Stock Unit done was reported to US exchanges on Aug. 8, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Oleh Nabyt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2025 29,240 29,240 - - Restricted Stock Unit
Joseph Tung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2025 29,240 29,240 - - Restricted Stock Unit
Timothy J. Lorber Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2025 24,854 24,854 - - Restricted Stock Unit
Timothy J. Lorber Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2025 29,240 29,240 - - Restricted Stock Unit
Steven Richards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2025 29,240 29,240 - - Restricted Stock Unit
George Scorsis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2025 29,240 29,240 - - Restricted Stock Unit
Steven Richards Director 31 Dec 2024 209,790 210,004 - 0 Common Stock
Joshua Schafer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 209,790 210,004 - 0 Common Stock
Joshua Schafer Director 31 Dec 2024 209,790 210,004 - 0 Common Stock
Milton Brown Director 31 Dec 2024 209,790 346,617 - 0 Common Stock
Steven Richards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 209,790 210,004 - 0 Common Stock
Mira Jung Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 11.28 per share. 01 May 2024 598 135,715 - 11.3 6,745 CLASS A COMMON STOCK
Michael P. Vander Hoek Chief Financial Officer 08 Mar 2024 100,000 103,852 - 0 COMMON STOCK
Milton Brown Director 13 Dec 2023 2,921 1,094,610 - 0.5 1,353 Common Stock
Jacobs Bette Director 13 Dec 2023 4,157 27,064 - 0.5 1,926 Common Stock
Anatoly Dritschilo Director, CEO and Chairman, Ten Percent Owner 14 Aug 2023 2,100,000 1,104,407 - 0 COMMON STOCK
Anatoly Dritschilo Director, CEO and Chairman, Ten Percent Owner 14 Aug 2023 2,100,000 2,100,000 - 0 COMMON STOCK
Milton Brown Director 15 Feb 2023 25,000 25,000 - - Stock Options
Christoopher H. Senanayake Director 29 Dec 2022 1,626 2,791 - 1.6 2,610 COMMON STOCK
Peter Dritschilo President and COO 29 Dec 2022 3,820 6,560 - 1.6 6,131 COMMON STOCK
Bette Jacobs Director 29 Dec 2022 4,366 31,221 - 1.6 7,007 CLASS A COMMON STOCK
William H. Adkins Former Director Other type of transaction at price $ 0.00 per share. 29 Dec 2022 138,889 138,889 - - WARRANTS (right to buy)
William H. Adkins Former Director Sale of securities on an exchange or to another person at price $ 1.61 per share. 29 Dec 2022 995 184,071 - 1.6 1,597 COMMON STOCK
Milton Brown Director 29 Dec 2022 995 1,072,531 - 1.6 1,597 COMMON STOCK
Steven Richards Director Sale of securities on an exchange or to another person at price $ 1.61 per share. 29 Dec 2022 995 1,707 - 1.6 1,597 COMMON STOCK
Tyvin A. Rich Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.60 per share. 29 Dec 2022 1,414 2,429 - 1.6 2,269 COMMON STOCK
Mira Jung Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.60 per share. 29 Dec 2022 328 1,071,388 - 1.6 526 CLASS A COMMON STOCK
Michael P. Vander Hoek Chief Financial Officer 29 Dec 2022 2,243 3,852 - 1.6 3,600 COMMON STOCK
Anatoly Dritschilo Director, CEO and Chairman, Ten Percent Owner 29 Dec 2022 8,372 1,085,200 - 1.6 13,437 COMMON STOCK
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters